Compounded Sermorelin

Sleep changes are often noticed within 1–2 weeks. Energy, mood, and recovery improvements typically appear at 4–6 weeks. Body-composition changes (lean mass, central fat) usually require 3–6 months of consistent use, and IGF-1 lab changes are measurable at 8–12 weeks. Individual results vary based on dose, sleep quality, training, and protein intake.

Most protocols use 5 nights on / 2 nights off weekly to preserve pituitary sensitivity. Some doctors recommend a longer break (about 1 month off after 3–6 months on). Cycling helps prevent receptor desensitization and keeps your body’s GH response responsive over the long run.

Yes — common compounded combinations include sermorelin + ipamorelin (dual-pathway GH release via both GHRH and ghrelin receptors) and sermorelin + CJC-1295 (longer-acting GHRH analog). Stacking should always be doctor-supervised, and your protocol may evolve over time based on labs and goals.

Growth hormone release is concentrated during deep (slow-wave) sleep, and patients commonly report improved sleep depth, fewer nighttime wake-ups, and better morning recovery. This is one of the most consistently reported subjective benefits of sermorelin therapy in the published literature.

Sermorelin has a multi-decade safety record and works with your body’s natural feedback loops, which limits supraphysiologic GH exposure. Routine monitoring of IGF-1, fasting glucose, and thyroid function is standard for ongoing use, and your prescribing doctor adjusts your protocol based on those labs.

HGH is exogenous growth hormone — it overrides your pituitary and supplies hormone directly. Sermorelin stimulates your pituitary to release its own GH in natural pulses, preserving feedback regulation. Sermorelin is legal to prescribe via 503A compounding; recombinant HGH requires a documented medical GH deficiency diagnosis and is heavily regulated.

Yes. Baseline labs (IGF-1, fasting glucose, HbA1c, TSH, free T4) are reviewed by your prescribing doctor before a prescription is issued. If you have recent labs (within 12 months), you can upload them; otherwise we coordinate at-home or in-network draws. IGF-1 is then rechecked at 8–12 weeks to confirm physiologic response and guide dose adjustments.

Peptide12 partners with state-licensed compounding pharmacies that hold state and federal licensure and undergo regular USP <797> sterility audits. Every batch is third-party tested for identity, potency, sterility, and endotoxin before release. Compounded sermorelin is not FDA-approved as a finished drug product but is prepared from FDA-regulated active ingredients under individualized prescription.

Compounded medications are typically not covered by commercial insurance. Many patients use HSA or FSA funds. Your care team can help you check eligibility and walk you through reimbursement documentation if needed.